199 related articles for article (PubMed ID: 38055156)
1. Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study.
Saito J; Nakamura H; Akabane M; Yamatani A
Ther Innov Regul Sci; 2024 Mar; 58(2):316-335. PubMed ID: 38055156
[TBL] [Abstract][Full Text] [Related]
2. Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan.
Saito J; Nadatani N; Setoguchi M; Nakao M; Kimura H; Sameshima M; Kobayashi K; Matsumoto H; Yoshikawa N; Yokoyama T; Takahashi H; Suenaga M; Watanabe R; Imai K; Obara M; Hashimoto M; Yamamoto K; Fujiwara N; Sakata W; Nagai H; Enokihara T; Katayama S; Takahashi Y; Araki M; Iino K; Akiyama N; Katsu H; Fushimi K; Takeda T; Torimoto M; Kishi R; Mitsuya N; Kihara R; Hasegawa Y; Hamada Y; Kimura T; Wada M; Tanzawa A; Yamatani A
J Pharm Health Care Sci; 2021 Jul; 7(1):23. PubMed ID: 34193299
[TBL] [Abstract][Full Text] [Related]
3. Exposure to potentially harmful excipients in medications among neonates at a state hospital in Malaysia.
Wong SW; Chew SP; Abdul Aziz SA; Mohamed Shah N
Drug Dev Ind Pharm; 2024 Mar; ():1-9. PubMed ID: 38459761
[TBL] [Abstract][Full Text] [Related]
4. Possible effects of excipients used in the parenteral drugs administered in critically ill adults, children, and neonates.
Sridharan K; Hasan HM; Al Jufairi M; Al Daylami A; Al Ansari E; Qader AM; Pasha SAA
Expert Opin Drug Saf; 2020 Dec; 19(12):1625-1640. PubMed ID: 32767900
[TBL] [Abstract][Full Text] [Related]
5. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
Shehab N; Lewis CL; Streetman DD; Donn SM
Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
[TBL] [Abstract][Full Text] [Related]
6. The Cumulative Daily Tolerance Levels of Potentially Toxic Excipients Ethanol and Propylene Glycol Are Commonly Exceeded in Neonates and Infants.
Valeur KS; Hertel SA; Lundstrøm KE; Holst H
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):523-530. PubMed ID: 29281181
[TBL] [Abstract][Full Text] [Related]
7. Safe excipient exposure in neonates and small children - protocol for the SEEN project.
Valeur KS; Hertel SA; Lundstrøm KE; Holst H
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157063
[TBL] [Abstract][Full Text] [Related]
8. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of ethanol and other potentially harmful excipients in pediatric oral medicines: survey of community pharmacies in a Nigerian City.
Soremekun R; Ogbuefi I; Aderemi-Williams R
BMC Res Notes; 2019 Jul; 12(1):460. PubMed ID: 31349864
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
[TBL] [Abstract][Full Text] [Related]
11. Harmful excipients in medicines for neonates in Spain.
Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
[TBL] [Abstract][Full Text] [Related]
12. Toxic excipients in medications for neonates in Brazil.
Souza A; Santos D; Fonseca S; Medeiros M; Batista L; Turner M; Coelho H
Eur J Pediatr; 2014 Jul; 173(7):935-45. PubMed ID: 24500397
[TBL] [Abstract][Full Text] [Related]
13. A retrospective and observational analysis of harmful excipients in medicines for hospitalised neonates in Latvia.
Sviestina I; Mozgis D
Eur J Hosp Pharm; 2018 Jul; 25(4):176-182. PubMed ID: 31157015
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines.
Stjepanovic AN; Todorovic NB; Tesic TZ; Komazec ZS; Canji-Panic JM; Lalic-Popovic MN
Regul Toxicol Pharmacol; 2022 Aug; 133():105225. PubMed ID: 35817211
[TBL] [Abstract][Full Text] [Related]
16. "Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs.
Pediatrics; 1997 Feb; 99(2):268-78. PubMed ID: 9024461
[TBL] [Abstract][Full Text] [Related]
17. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse.
Moench TR; Mumper RJ; Hoen TE; Sun M; Cone RA
BMC Infect Dis; 2010 Nov; 10():331. PubMed ID: 21087496
[TBL] [Abstract][Full Text] [Related]
18. Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates.
Nellis G; Metsvaht T; Varendi H; Lass J; Duncan J; Nunn AJ; Turner MA; Lutsar I
Paediatr Drugs; 2016 Jun; 18(3):221-30. PubMed ID: 27099961
[TBL] [Abstract][Full Text] [Related]
19. Biologic excipients: Importance of clinical awareness of inactive ingredients.
Ionova Y; Wilson L
PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
[TBL] [Abstract][Full Text] [Related]
20. [Study on selecting the suitable solubilizing excipients for Shengmai injection].
Zhang SF; Yan D; Tang HY; Li HB; Wang YS; Xiao XH; Yang M
Zhong Yao Cai; 2009 Jun; 32(6):969-72. PubMed ID: 19764337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]